Heart failure in the adult patient with congenital heart disease

Folia Cardiologica

Volumn 14, Issue 2, 2007, Pages 127-136

  Trojnarska, Olga ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adult patients with congenital heart disease; Heart failure

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; AMIODARONE; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CD14 ANTIGEN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; INTERLEUKIN 10; INTERLEUKIN 6; NEUROHORMONE; NORADRENALIN; OXYGEN; RENIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; BICYCLE ERGOMETRY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR SURGERY; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; COMORBIDITY; CONGENITAL HEART DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG MECHANISM; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; GREAT VESSELS TRANSPOSITION; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART FAILURE; HEART PERFORMANCE; HEART PRELOAD; HEART SOUND; HEART TRANSPLANTATION; HEART VALVE REPLACEMENT; HEART VENTRICLE CONTRACTILITY; HEPATOMEGALY; HEREDITY; HORMONAL REGULATION; HUMAN; MEDICAL RESEARCH; MUSTARD OPERATION; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PATIENT CARE; PERIPHERAL EDEMA; PRACTICE GUIDELINE; PROGNOSIS; PSYCHOLOGICAL ASPECT; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW; SYMPTOM; TACHYCARDIA; TRICUSPID VALVE REGURGITATION;

EID: 34247472552     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Reme WJ, Swedberg K, Cleland J et al. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J, 2001; 22: 1527-1560.
2. McMurray JJ, Stewart S. Epidemiology, aetiology and prognosis of heart failure. Heart, 2000; 83: 596-602.
3. Bolger AP, Coast AJ, Gatzoulis MA. Congenital heart disease: the original heart failure syndrome. Eur Heart J, 2003; 24: 970-976.
4. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol, 1993; 71: 1106-1107.
5. Warnes CA, Somerville J. Tricuspid atresia in adolescents and adults: current state and late complications. Br Heart J, 1986; 56: 535-543.
6. Perloff JK, Child JS. Congenital heart disease in adults. W.B. Saunders Company, Philadelphia 1998: 194.
7. Bolger AP, Sharma R, Li W et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation, 2002; 106: 92-99.
8. Veldtman GR, Nishimoto A, Siu S et al. The Fontan procedure in adults. Heart, 2001; 86: 330-335.
9. Davlourous PA, Kilner PJ, Hornung TS et al. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol, 2002; 40: 2044-2052.
10. de Ruijter FT, Weenink I, Hitchcock FJ, Meijboom EJ, Bennink GB. Right ventricular dysfunction and pulmonary valve replacement after correction of tetralogy of Fallot. Ann Thorac Surg, 2002; 73: 1794-1800.
11. Graham TP, Jr., Bernard YD, Mellen BG et al. Long-term outcome in congenitally corrected transpositions of the great arteries: a multi-institutional study. J Am Coll Cardiol, 2000; 36: 255-261.
12. Francis DP, Shamim W, Davies LC et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO2 slope and peak VO2. Eur Heart J, 2000; 21: 154-161.
13. Fredriksen PM, Veldtman G, Heachter S et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol, 2001; 87: 310-314.
14. Diller GP, Dimopaulos K, Okano D, Li W et al. Exercise intolerance in adult congenital heart disease. Comparative severity, correlates and prognostic implications. Circulation, 2005; 112: 828-835.
15. Trojnarska O, Szyszka A, Gwizdała A et al. Evaluation of exercise capacity with cardiopulmonary exercise testing with type B natriuretic peptide concentrations in adult patients with patent artial septal defect. Cardiology, 2006; 106: 154-160.
16. Sarubbi B, Pacileo G, Pisacone C et al. Exercise capacity in young patients after tetralogy of Fallot. Pediatr Cardiol, 2000; 21: 211-215.
17. Trojnarska O, Szyszka A, Gwizdała A et al. The BNP concentration and exercise capacity assessment with cardiopulmonary stress test in patients after surgical repair of tetralogy of Fallot. Int J Cardiol, 2005; 110: 86-92.
18. Fredriksen PM, Chen A, Veldtman G et al. Exercise capacity in adult patients with corrected transposition of the great arteries. Heart, 2001; 85: 191-195.
19. Trojnarska O, Szyszka A, Gwizdała A et al. Adult patients with Ebstein's anomaly - cardiopulmonary exercise testing and BNP level. Int J Cardiol, 2006; 111: 92-97.
20. Glasser S, Opitz CF, Bauer U et al. Assessment of symptoms and exercise capacity in cyanotic patients with congenital heart disease. Chest, 2004; 125: 368-376.
21. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med, 2001; 345: 574-581.
22. Presbitero P, Somerville J, Rabajoli F. Corrected transposition of the great arteries without associated defects in adult patients: clinical profile and follow-up. Br Heart J, 1995; 74: 57-59.
23. Puley G, Siu S, Connelly M. Arrhythmia and survival in patients > 18 years of age after the Mustard procedure for complete transposition of the great arteries. Am J Cardiol, 1999; 83: 1080-1084.
24. Taylor DO, Edwards LB, Mohacsi PJ. The Registry of The International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report: 2003. J Heart Lung Transplant, 2003; 22: 616-624.
25. Kilbridge PM, Mayer JE, Newburger JW, Hickley PL, Walsh AZ, Neufeld EJ. Induction of intercellular adhesion molecule-1 and E-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass J Thorac Cardiovasc Surg, 1994; 107: 1183-1192.
26. Horning TS, Kilner PJ, Davlouros PA. Excessive right hypertrophic response in adults with Mustard procedure for transplantation of the great arteries. Am J Cardiol, 2002; 90: 800-803.
27. Lubiszewska B, Gosiewska E, Hoffman P et al. Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long term follow-up. J Am Coll Cardiol, 200; 36: 1365-1370.
28. Kirjavainen M, Happonen J, Louhimo I. Late results of Senning operation. J Thorac Cardiovasc Surg, 1999; 117: 488-495.
29. Piran S, Veldtman G, Siu S, Webb G, Liu PP. Heart failure and ventricle dysfunction in patients with single or systemic right ventricles. Circulation, 2002; 105: 1189-1194.
30. Beauchese LM, Warnes CA, Connolly HM. Outcome of the unoperated adult who presents with congenitally corrected transposition of the great arteries. J Am Coll Cardiol, 2002; 40: 285-290.
31. Dodge-Khatami A, Tulevski II, Bennink GB. Comparable systemic ventricular function in healthy adults and patients with unoperated congenitally corrected transposition using MRI dobutamine stress testing. Ann Thorac Surg, 2002; 73: 1759-1764.
32. Eicksen A, Fratz S, Gutfried C. Hearts late after Fontan have normal mass, normal volume and reduced systolic function. J Am Coll Cardiol, 2003; 42: 1061-1065.
33. Hauser M, Bengel FM, Kuhn A. Myocardial perfusion and coronary flow reserve assessed by positron emission tomography in patients after Fontan-like operations. Pediatr Cardiol, 2003; 24: 386-392.
34. Senzaki H, Masutani S, Kobayashi J et al. Ventricular afterload and ventricular work in Fontan circulation: comparison with two-ventricle circulation and single-ventricle circulation with Blalock-Taussig shunts. Circulation, 2002; 105: 2885-2892.
35. Weber KT, Brilla CG. Pathological hypertrophy and cardiac intersticium. Circulation, 1991; 83: 1849-1856.
36. Tulewski II, Lee PL, Groening M. Dobutamine induced increase of right ventricle contractility without increased stroke volume in adolescent patients with transposition of the great arteries: evaluation with magnetic resonance imaging. Int J Cardiol Imag, 2000; 16: 471-478.
37. Hornung TS, Siu SC, Osten M. Medium-term outcome after atrial arrhythmia surgery in adult patients with congenital heart disease. Pediatric Cardiol, 2003; 19: 486A.
38. Vantrimpont P, Rouleau JL, Ciampi A. Two years time course and significance of neurohormonal activation in the SAVE study. Eur Heart J, 1998; 19: 52-63.
39. Sharma R, Bolger AP, Li W et al. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol, 2003; 92: 188-193.
40. Holmgren D, Westerlind A, Lundberg PA, Wahlandre N. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload. Clin Physiol Funct Imag, 2005; 25: 263-269.
41. Tulewski II, Groenink M, van der Wall EE et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart, 2001; 86: 27-30.
42. Hopkins WE, Chen Z, Fukagava NK et al. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease. Enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation, 2004; 109: 2872-2877.
43. Iivainen TE, Groundstroem KWE, Lahtela JT, Talvensaari TJ, Pasternack A, Uusitalo A. Serum N-terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect. Eur Heart J, 2000; 2: 161-165.
44. Ohuchi H, Takasugi H, Ohashi H et al. Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in Fontan patients. Circulation, 2004; 110: 2601-2608.
45. Nir AQ, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiol. J Card Fail, 2005; 11: 76-80.
46. Shwarc PJ. The autonomic nervous system and sudden cardiac death. Eur Heart J, 1998; 19 (suppl. F): 72-80.
47. Trojnarska O, Wachowiak-Baszyńska H, Ochotny R, Cieśliński A. Zaburzenia rytmu, dyspersja QT i zmienność rytmu zatokowego u dorosłych chorych po korekcji tetralogii Fallota. Folia Cardiol, 2001; 8: 673-678.
48. Davos CH, Davlouros PA, Wensel R. Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation, 2002; 106 (suppl. 1): 169-175.
49. Ohuchi H, Hasegava S, Yasuda K, Yamada O, Ono Y, Echigo S. Severely impaired cardiac autonomic nervous activity after the Fontan operation. Circulation, 2001; 104: 1513-1518.
50. Lequier LL, Nikaidoch H, Leonard SR et al. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest, 2000; 117: 1706-1712.
51. Mou SS, Haudek SB, Lequier L et al. Myocardial inflammatory activation in children with congenital heart disease. Crit Care Med, 2002; 30: 827-832.
52. Force T, Michael A, Killer H. Stretch-activation pathways and left ventricular remodelling. J Card Fail, 2002; 8: 351-358.
53. Book WM. Heart failure in adult patients with congenital heart disease. J Card Fail, 2005; 11: 306-312.
54. Hechter SJ, Fredriksen PM, Liu P, Veldtman G, Merchant N, Freeman M. Angiotensin converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol, 2001; 87: 660-663.
55. Robinson B, Heise CT, Moore JW, Anella J, Sokoloski M, Eshaghpour E. Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries. Pediatr Cardiol, 2002; 23: 618-623.
56. Kouatli AA, Garcia JA, Zellers TM, Weinstein EM, Mahony L. Enalapril does not enhance exercise capacity in patients after the Fontan procedure. Circulation, 1997; 96: 1507-1512.
57. Lester SJ, McElhinney DB, Viloria E et al. Effects of losartan in patients with systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am J Cardiol, 2001; 88: 1314-1316.
58. Dore A, Houde C, Chan KL et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricle - a multicenter, randomized, placebo-controlled clinical trial. Circulation, 2005; 112: 2411-2416.
59. Hopkins WE, Kelly DP. Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease. Am J Cardiol, 1996; 77: 439-440.
60. Lindenfeld J, Keller K, Campbell DN, Wolfe RR, Quaife RA. Improved systemic ventricular function after carvedilol administration in a patient with congenitally corrected transposition of the great arteries. J Heart Lung Transplant, 2003; 22: 198-201.
61. Ringel RE, Peddy SB. Effect of high dose spironolactone on protein loosing enteropathy in patients with Fontan palliation of complex congenital heart disease. Am J Cardiol, 2003; 91: 1031-1032.
62. Warnes CA. The adult with congenital heart disease. Born to be bad? J Am Coll Cardiol, 2005; 46: 1-8.
63. Somerville J. Grown-up congenital heart (GUCH) disease: Current needs and provisions of service for adolescents and adults with congenital heart disease in the UK. Heart, 2002; 88: 11-14.
64. Deal RJ, Mavroudine C, Backer CL. Beyond Fontan conversion: surgical therapy of arrhythmias including patients with associated complex congenital heart disease. Ann Thorac Surg, 2003; 76: 542-544.
65. Leon AR, Greenberg JM, Kanuru N et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol, 2002; 39: 1258-1263.
66. Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare CG, Rosenthal DN. Electrical resynchronisation: a novel therapy for the failing right ventricle. Circulation, 2003; 107: 2287-2289.
67. Lamour JM, Addonizio LJ, Galantowucz ME et al. Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. Circulation, 1999; 100: 200-205.
68. Gamba A, Merlo M, Fiocchi R et al. Heart transplantation in patients with previous Fontan operation. J Thorac Cardiovasc Surg, 2004; 127: 555-562.
69. Waddell TK, Bennett L, Kennedy R, Todd TRJ, Keshavjee SH. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant, 2002; 21: 731-737.